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CLINICAL STUDIES
From the Midwestern Vascular Surgical Society
In August 1998, Mike Singletary was admitted
to the Football Hall of Fame—a crowning achieve-
ment for a great athlete. In his acceptance speech, he
talked about his teachers and coaches and the lessons
that they taught him on the road to his success. I
think that we all should remember where we came
from and those who helped us to achieve success. It
is my turn to recognize some important people in
my personal and professional lives, individuals who
got me where I am today. My mother would proba-
bly get the biggest kick out of seeing her son here
today. She taught me to aim high and do the right
thing, a lesson that was not all that easy to learn at
times. My father is a surgeon, a country boy from
Alabama, who has walked the halls with Presidents
and powerful men, who survived the fury of a terri-
ble World War, and who taught me to respect and
honor my fellow man. My wife Sandy has been the
rock on which my adult life has been built. As friend
and advisor, critic and cheerleader, she has kept me
on an even keel for 25 years. Robert Zollinger was
my mentor. He taught me lessons in many ways: he
used pain and fear mixed with humor and compas-
sion to make me and all of his residents learn to
honor and respect our surgical profession. Bill Evans
(Columbus, Ohio) taught me to appreciate great tal-
ent and to let the talented be the best that they can
be without resentment. Jim Stanley (Ann Arbor,
Mich) showed me that knowledge is power and that
science is the bedrock of our profession. Bill Baker
(Chicago, Ill) has shown me the value of humor and
how it helps get the job done when there is nothing
funny about the job. Jim Yao (Chicago, Ill) taught
me that enthusiasm is a force multiplier, and John
Towne (Milwaukee, Wis) taught me how to dodge
political spears, how to not spill my own profession-
al blood, and how to negotiate in good faith. Finally,
I cannot forget Norman Hertzer (Cleveland, Ohio),
the quiet, articulate leader, with the tenacity of a pit
bull. He taught me that we must be more than just
good surgeons if we are to survive in the current
socioeconomic environment. We must become part
of the political process to influence change and to
ultimately protect and serve our patients and our-
selves.
The title of my talk “Looking back to the future”
is not unique. Movies, editorials, and more than one
presidential address have been so entitled. The title
suggests that there are lessons to be learned from
past experiences, which can be of value in solving the
problems of the present. This idea came to me this
past spring, while I was on a trip to Turkey with the
members of the Wisconsin Surgical Travel Club.
One day, in a small village in the central part of the
country, we stopped at a roundabout. In the city
square, there was a bronze statue of an old man rid-
ing backwards on a donkey. Curious about the stat-
ue, I asked our guide about its significance. He told
me about the hoca (an ancient teacher or wise man)
and the story about the curious disciple, who asked
the same question that I was asking him, 500 years
earlier. The teacher’s explanation to his student was
that “to understand where you are going, you must
know where you have been.” The teaching of the
hoca suggests that there are timeless, simple truths
and principles that can be of use in solving complex
and confusing problems. These principles may be of
value in dealing with the changes that affect the sur-
gical profession and, in particular, our specialty of
vascular surgery. These principles embody and con-
stitute wisdom, which can be defined as the ability 
to discern inner qualities and relationships—the 
possession of good sense, insight, and judgement.
Unfortunately wisdom is not necessarily the reward
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for knowledge and intelligence. Arrogance, apathy,
distrust, and pride can overwhelm wisdom and con-
demn us to relive the failures of the past.
Today, I will comment on how some basic princi-
ples compiled by Colin Powell, one of our present-
day wise men, can apply to the problem solving of
current controversies in vascular surgery. Many of
you probably have read the book he wrote entitled
“My American journey.” In the text of the book,
there is a list of Colin Powell’s rules (Table I).1 These
are caveats of wisdom accumulated during the course
of his military career. Selected rules apply to many
critical issues of concern in our profession today.
These issues include the integration of clinical vascu-
lar services, relationships with the American Board of
Surgery, emerging technologies, research and educa-
tion, and finally the role of the Midwestern Vascular
Surgical Society.
INTEGRATION OF CLINICAL SERVICES
To react to change, it is important to understand
why and how the forces of change have emerged.
Much can be explained by the incredible magnitude
of growth and development in the basic and medical
sciences and technology that have occurred since the
turn of the century. We have lifted ourselves off the
surface of the earth and propelled ourselves to the
planets, and we now flirt with the potential of recre-
ating ourselves and controlling the genetics and
microbiology of disease processes, which in the nat-
ural scheme of things keeps our population in bal-
ance with its surroundings.
Our population is growing logarithmically, aging
rapidly, and not dying. The aged require more and
more support from the system and have come to
expect it while the dwindling work force labors
harder to keep the system going. The fact of the
matter is that health care costs have grown well
beyond society’s desire or ability to pay for them.
For example, in 1960, health care costs constituted
5% of the gross national product as compared with
14% in 1994. It is predicted that by 2020 the costs
may exceed 30%.2 Expenditures have not declined
despite attempts at cost containment. Only the rate
of increase has declined. Despite rather savage cut-
backs in physician fees by Medicare in the past 10
years, health care spending has increased by 12% to
15%. Our efficient health care system is essentially
collapsing under its own weight. More and more
adults are surviving long enough to contract vascu-
lar disease, which kills or disables more people than
any other single malady today. It is predicted that
the number of vascular cases necessary for the ade-
quate treatment of the population in 2020 will
increase by more than 11⁄2 million procedures. If the
output of specialty-trained vascular surgeons were to
be increased by 30 graduates a year for the next 20
years, it is unlikely that the predicted clinical needs
would be adequately met. 
The prediction of the manpower needs for the
treatment of our enlarging geriatric population in
the 21st century is difficult, if not impossible. It is
simply not prudent to expand surgical training pro-
grams without accurate data if quality is to be main-
tained and costs controlled.3 At the same time, there
is clear evidence emerging from prospective clinical
studies to suggest that there is a direct correlation
between improved clinical outcomes data, patient
satisfaction, and cost containment when vascular
cases are performed by fellowship-trained and spe-
cialty-certified surgeons who perform a high volume
of vascular cases annually. Clearly, it is unreasonable
to expect that the generalists in medicine or surgery
can provide quality care at a reduced cost for this
patient population.4,5 It will indeed be a challenge
to continue to produce adequately trained caregivers
when the government threatens to constrict funded
training to 5 years or less. This action will make cur-
riculum-based surgical education with fast-track
focus on specialty training a necessity.6 The real
question is: do we have to do it all ourselves?
Each year, 180 specialty-trained interventional
radiologists graduate from 130 postgraduate pro-
grams in the United States and Canada. The new
generation of interventionalists are interested in
patient care and want to have admitting privileges
and be directly involved in management decision
making. Furthermore, there are 425 cardiology fel-
lowship programs in the United States and half of
these graduates specialize in interventional cardiolo-
JOURNAL OF VASCULAR SURGERY
764 Turnipseed May 1999
Table I. Colin Powell’s rules
1. It ain’t as bad as you think. It will look better in the morn-
ing.
2. Get mad, then get over it.
3. Avoid having your ego so close to your position that when 
your position fails, your ego goes with it.
4. It can be done!
5. Be careful what you choose. You may get it.
6. Don’t let adverse facts stand in the way of good decision.
7. You can’t make someone else’s choices. You shouldn’t let 
someone else make yours.
8. Check small things.
9. Share credit.
10. Remain calm. Be kind.
11. Have a vision. Be demanding.
12. Don’t take counsel of your fears or naysayers.
13. Perpetual optimism is a force multiplier.
gy. The American Board of Internal Medicine is
establishing criteria for specialty training in vascular
medicine. These credentials will most likely be vest-
ed in physicians trained in cardiology. Clearly, there
will be no shortage of clinicians interested in and
potentially capable of treating vascular disease in the
future. Will we be able to support competitive agen-
das in the 21st century when we are essentially treat-
ing the same disease?
Vascular surgeons should be proud of the accom-
plishments in the field. They have set a standard of
excellence for the diagnosis and treatment of vascu-
lar disease and its complications. Vascular surgery
has matured and become an information-based sci-
entific discipline, which developed the concept of
life-table analysis, used prospective randomized clin-
ical trials early on, and accelerated the development
of noninvasive testing. Today, its focus has expanded
to include basic investigation into the genetics and
microbiology of atherosclerosis. Although vascular
surgeons are intrigued by endovascular advances,
such as balloon angioplasty and intraluminal stent-
ing, few in our specialty embraced endovascular
therapeutics until the development of endografts for
the treatment of aortic aneurysm and occlusive dis-
ease. This suddenly became a threat to our control
of the treatment of peripheral vascular disease, and
we are now frantically embracing catheter-based
techniques as our own. Will pride get in the way of
wisdom? We are not, by traditional training,
catheter-based specialists. Now we want to be. Can
we ignore our better trained colleagues in radiology
and cardiology and “do it all ourselves”? The answer
is: probably not.
We cannot afford duplicity, redundant infrastruc-
ture, or internal competition, particularly in the face
of managed care and foundation structures, which
operate on a bottom-line budget. Furthermore,
without adequate training, our own ability to deliv-
er quality care in this sector of vascular disease man-
agement may be seriously questioned. There is no
doubt that we can be part of the action, but it is
unlikely that we will dominate the market share of
endovascular therapeutics in the future. We desper-
ately need a system whereby the orderly training of
endovascular subspecialists and the delivery of vas-
cular health care services in the 21st century can be
assured. The concept of the Vascular Disease Center
may allow all of this to happen. Departmental influ-
ence will fade to some extent as vascular physicians
become trained in the specifics of diagnosis and the
alternative methods of interventional care. Surgeons
will still need to be surgeons. Failure of transition
devices will most likely necessitate a new generation
of bail-out or recovery procedures. Carotid bypass
grafting, for example, may become a common oper-
ation in the next 3 to 5 years if we cannot figure how
to beat intimal hyperplasia.
As surgeons, we also have an implicit obligation
to try and improve the bench mark operations on
which we structure our current practice. Little atten-
tion has been focused on minimally invasive vascular
surgery. It is possible that the durable performance
of traditional grafting procedures can be coupled
with reduced hospital stay, reduced costs, improved
patient satisfaction, and less demanding surveillance
protocols by reducing the invasive nature of our cur-
rent operations.
Cross training of fellows in surgery, cardiology,
and radiology is possible with the Vascular Disease
Center concept. Infrastructure costs, personnel
requirements, reduplication, and internal competi-
tion can be controlled if training programs are inte-
grated. However, if this proposal is to succeed, the
nonsurgical disciplines will have to be willing to
accept what vascular surgeons have already learned
in the past five decades. Pretty pictures, anecdotal
experience, and no follow-up are unacceptable stan-
dards for clinical practice. If we ignore the disciplines
that want to be part of the 21st century vascular care
package or if they choose to ignore us, there will
develop a system of parallel agendas that will ulti-
mately reduce the quality of care that patients
receive, make their clinical outcomes less pre-
dictable, and, at the same time, increase manage-
ment costs.
As we face the vexing issue of redesigning inter-
specialty alignments and training, we should perhaps
remember the following postulates: “Don’t take
counsel of your fears or naysayers; Don’t let adverse
facts get in the way of good decisions; It’s not as bad
as you think; It can be done!”1
RELATIONSHIP WITH THE AMERICAN
BOARD OF SURGERY
I would like to take a short moment to look back
at the interaction between the American Board of
Surgery and the leadership of the joint Vascular
Surgical Societies. Twenty-five years ago, Edwin
Wiley suggested that a standard of excellence could
be achieved by the establishment of specific residen-
cy training programs. In 1972, the Society of
Vascular Surgery established the program evaluation
committee to accredit vascular surgical training pro-
grams. But it was not until 1982 that the American
Board of Medical Specialties allowed the first certi-
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fying examination to be administered. It took a
decade to get down to the basic issue of measuring
quality and training requirements for vascular sur-
geons. Concern about the rapid growth and change
in the practice of vascular surgery and the slow
response to change by the American Board of
Surgery forced the contentious proposal that a new
board for vascular surgery be formed.3 Egos, pride,
and turf issues threatened to polarize general and
vascular surgical camps to a point where objective
dialog between the American Board of Surgery and
the vascular surgical community could not be sal-
vaged.
In the beginning, many members of the vascular
surgical societies were uncertain about what the pri-
mary issues were. They seemed to think that a new
board was appropriate because of the general sense
that the American Board of Medical Specialties and
the American Board of Surgery were unwilling to
allow greater responsibility and authority for defin-
ing how vascular surgeons were trained and certi-
fied. Fortunately, a dialogue was established, objec-
tives were mapped out, and a template was created
for a sub board of vascular surgery.
Leaders on the American Board of Surgery and
the council of the Joint Vascular Societies have nego-
tiated an agreement that can work, avoid political
debate, and prevent similar unrest by other specialties
in the community of surgeons. Both sides must trust
one another and work together in good faith. The
Joint Council, in its letter June 11, 1998, to the
American Board of Surgery, clearly outlined a plan
that defines the role and activities of the sub board.
We cannot afford to let this project fail. Both sides
should share credit for its success or for its failure.
Colin Powell’s rules apply to the negotiations
between these two parties. For those who are over-
whelmed by personal involvement, “avoid having
your ego so close to your position that when your
position fails, your ego goes with it; get mad and get
over it.”l For those who want a board that is inde-
pendent of the American Board of Surgery, “be care-
ful what you choose, you might get it.”1 At least
give the system a chance to work. Our leaders in vas-
cular surgery have clarified a “vision” and plan for
the future. They should “be demanding” and “make
it succeed.”1
EMERGING TECHNOLOGIES
Emerging technologies have created great
enthusiasm and some concern among vascular sur-
geons because endovascular therapeutics now com-
pete with traditional surgical procedures for the
management of occlusive and aneurysmal disease.8
Balloon angioplasty and wall stents have proven
effective for the treatment of short segment, noncal-
cified, occlusive lesions in the cardiac and peripheral
circulation. Covered stents have shown promise in
the treatment of some penetrating vascular injuries
and in the management of aortic dissection and aor-
toiliac aneurysm disease. These treatments necessi-
tate competence with catheter-based techniques.
Routine angioplasty and wall stent placement can be
performed percutaneously. However, introduction
of the larger covered stents still necessitates surgical
exposure and introduction through femoral arteri-
otomies, temporarily creating a need for the pres-
ence of the surgeon in the endovascular suite. In the
near future, however, it is entirely possible that cov-
ered stents will be placed percutaneously.
If the surgeon is going to play an important clin-
ical role in the growth and development of endovas-
cular therapies, it will be necessary to achieve com-
petence in catheter-based techniques. Standards for
training and competency must be established.
Designated endovascular specialists within surgical
groups can become the bridge to integrate tradi-
tional surgical fellowship training with skills current-
ly taught in interventional cardiology and radiology.
If patient welfare is placed as first priority, these dis-
ciplines will work together to determine the most
appropriate roles for endovascular therapies. The
vascular surgeon can be extremely helpful in this
process. Because we are experienced with prospec-
tive clinical trials, experts in noninvasive testing and
surveillance, and founders of the first national reg-
istry for endovascular treatments, we bring a wealth
of information and experience to the table that are
not uniformly shared by other disciplines.
If we go our separate ways, God help the
patients! It is quite likely that unnecessary proce-
dures will abound, that unnecessary complications
will arise, and that more surgical procedures will be
necessitated, not because of disease severity, but
because of poorly selected use of endovascular tech-
niques. We need to “check the small details, share
credit, and should not let others make our choices”
about performing endovascular procedures.1
RESEARCH
The role that vascular surgery will play in clinical
and basic research appears bright indeed. Lord
William Kelvin, a famous British physicist and math-
ematician, once defined the physical sciences in the
following way: “when you can measure what you are
speaking about, and express it in numbers, you
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know something about it; when you cannot measure
it or express it in numbers, your knowledge is of a
meager kind.”7 Vascular surgery has emerged from
an artful form of surgery into a database specialty.
Vascular surgeons must continue to pursue basic sci-
entific interest without bias or preconception.
Outcomes can be measured and mathematically
expressed for basic and clinical research.
The Lifeline Foundation represents a commit-
ment of the vascular surgical specialty to the unfet-
tered high-quality pursuit of knowledge. Originally
conceived to compensate for the dwindling govern-
ment support of basic research, the new initiatives of
the Lifeline Foundation, supported by a grant from
the William Von Liebig Foundation and the
National Heart, Lung, and Blood Institute, are des-
ignated to stimulate interest in clinical research as
well. This year, the first national registry for
endovascular procedures will begin. Your financial
help and support of the Lifeline Foundation is
absolutely critical for the success of this effort. As
many of you know, until the first of this coming year,
the donations to Lifeline Foundation that are ear-
marked for the clinical research section will be
matched by an anonymous donor, dollar for dollar,
up to one million dollars. What better investment
could you make in our future?
MIDWESTERN VASCULAR SURGICAL
SOCIETY
Finally, what can be said about the Midwestern
Vascular Surgical Society? I was present in Buffalo in
1976 when John Bergen and Jack Pfeiffer held a
founders’ committee meeting during the Central
Surgical Association Meeting. The following objec-
tives for the new regional vascular society were
agreed on at that time: the advancement of the sci-
ence and art of peripheral vascular surgery and the
maintenance of high standards in the practice of
peripheral vascular surgery. I wonder if it is not time
to broaden our membership to include endovascular
specialists and to more aggressively focus society
activity in the area of socioeconomic issues. We are
being equated more and more to industrial workforce
and management algorithms in our daily surgical
practices. We do not have a union, yet! As individuals,
we have a weak voice in the halls of government. The
Midwestern Vascular Surgical Society in concert with
the Joint Vascular Surgical Societies, the American
College of Surgeons, and the American Medical
Association need to have regional and national agen-
das to protect and stress our interests and concerns.
Through coordinated strategies, objective informa-
tion can be provided to the healthcare agencies, which
ultimately decide our future.
In conclusion, wisdom suggests that the changes
we face and that the questions we currently harbor can
be appropriately answered if: we “hold to a common
vision;” “share credit” where it is due; “remain calm;”
and “maintain a perpetual sense of optimism.”1
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